S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CRNX Crinetics Pharmaceuticals Inc

58.78

-1.23 (-2.05%)

After Hours

Last Updated: 15:25:28

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/03/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

09/25/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Dana Pizzuti

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Crinetics Pharmaceuticals (NASDAQ:CRNX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Crinetics Pharmaceuticals Charts.

Crinetics Pharmaceuticals (NASDAQ:CRNX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Crinetics Pharmaceuticals Charts.

Crinetics Pharmaceuticals Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 hours ago) • Edgar (US Regulatory)

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
Tuesday 12 November 2024 (2 hours ago) • GlobeNewswire Inc.

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Tuesday 12 November 2024 (2 hours ago) • GlobeNewswire Inc.

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 11 November 2024 (1 day ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 16 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 10 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 9 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 9 October 2024 (1 month ago) • Edgar (US Regulatory)

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Tuesday 8 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 8 October 2024 (1 month ago) • Edgar (US Regulatory)

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Tuesday 8 October 2024 (1 month ago) • GlobeNewswire Inc.

More Crinetics Pharmaceuticals Inc News Articles

Moon Equity (PK)

Ronn Motor (PK)

TransCode Therapeutics

Kraig Biocraft Laborator... (QB)

Movement Industries (PK)

Digital Brand Media and ... (PK)

Code Green Apparel (PK)

FuelCell Energy

Clean Vision (QB)

Fannie Mae (QB)

Good Vibrations Shoes (PK)

Valiant Eagle (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions